Journal of Biological Chemistry
Volume 280, Issue 46, 18 November 2005, Pages 38673-38681
Journal home page for Journal of Biological Chemistry

Protein Synthesis, Post-Translation Modification, and Degradation
Regulation of the Cytoplasmic Quality Control Protein Degradation Pathway by BAG2*

https://doi.org/10.1074/jbc.M507986200Get rights and content
Under a Creative Commons license
open access

The cytoplasm is protected against the perils of protein misfolding by two mechanisms: molecular chaperones (which facilitate proper folding) and the ubiquitin-proteasome system, which regulates degradation of misfolded proteins. CHIP (carboxyl terminus of Hsp70-interacting protein) is an Hsp70-associated ubiquitin ligase that participates in this process by ubiquitylating misfolded proteins associated with cytoplasmic chaperones. Mechanisms that regulate the activity of CHIP are, at present, poorly understood. Using a proteomics approach, we have identified BAG2, a previously uncharacterized BAG domain-containing protein, as a common component of CHIP holocomplexes in vivo. Binding assays indicate that BAG2 associates with CHIP as part of a ternary complex with Hsc70, and BAG2 colocalizes with CHIP under both quiescent conditions and after heat shock. In vitro and in vivo ubiquitylation assays indicate that BAG2 is an efficient and specific inhibitor of CHIP-dependent ubiquitin ligase activity. This activity is due, in part, to inhibition of interactions between CHIP and its cognate ubiquitin-conjugating enzyme, UbcH5a, which may in turn be facilitated by ATP-dependent remodeling of the BAG2-Hsc70-CHIP heterocomplex. The association of BAG2 with CHIP provides a cochaperone-dependent regulatory mechanism for preventing unregulated ubiquitylation of misfolded proteins by CHIP.

Cited by (0)

2

An Established Investigator of the American Heart Association and a Burroughs Well-come Fund Clinical Scientist in Translational Research. To whom correspondence may be addressed: Carolina Cardiovascular Biology Center, 8200 Medical Biomolecular Research Bldg., Chapel Hill, NC 27599-7126. Tel.: 919-843-6477; Fax: 919-843-4585; E-mail: [email protected].

*

This work was supported by National Institutes of Health Grant GM61728 (to C. P.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.